HealthQuill Abbott Laboratories
Abbott Laboratories has initiated a clinical trial to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a form of major depressive disorder.
Drugs Health Pharma

Abbott starts trial on deep brain stimulation for depressive disorder

Abbott Laboratories has initiated a clinical trial to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a.

Read More
Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for treating type 2 diabetes.
Drugs Health Medical Pharma

Cipla, Novartis team up to make, market anti-diabetic drug

HQ Team April 10, 2023: Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for.

Read More
Abbott Laboratories has agreed to buy medical device maker Cardiovascular Systems for about $890 million.
Drugs Pharma

Abbott to acquire Cardiovascular Systems for $890 million

Abbott Laboratories has agreed to buy medical device maker Cardiovascular Systems for about $890 million.

Read More
X